Market Overview:
The global leg ulcers treatment market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of leg ulcers, rising awareness about available treatments, and technological advancements in wound care products. Based on type, the global leg ulcers treatment market is segmented into wound care dressings, biologics, therapy devices, and others. The wound care dressings segment is further sub-segmented into traditional dressings and advanced dressings. The advanced dressings sub-segment is expected to grow at a higher CAGR than the traditional dressing sub-segment during the forecast period from 2018 to 2030. This can be attributed to their ability to provide better healing outcomes for patients with chronic wounds such as leg ulcers. Based on application, the global leg ulcers treatment market is segmented into hospital and clinic settings.
Product Definition:
A leg ulcer is a wound that does not heal within a normal time frame. The most common cause of leg ulcers is venous insufficiency, which is when the veins in the legs do not efficiently pump blood back to the heart. Other causes of leg ulcers include arterial insufficiency, diabetes, and pressure from ill-fitting shoes or clothing. Leg ulcers may also be caused by infection or skin conditions such as psoriasis or eczema.
Treatment for leg ulcers includes regular cleaning and dressing of the wound, elevation of the affected limb, compression therapy to improve blood flow in the veins, and antibiotics if an infection is present.
Wound Care Dressings:
Wound care dressings are used for treating various types of wounds. The wound care dressing is a type of medical device that helps in protecting and healing skin injuries. These products are majorly used on chronic or acute wounds, which have failed to heal naturally. Wound care dressings can be classified as advanced, basic, and traditional depending upon the properties they exhibit such as moisture management ( Advanced ), antibacterial protection ( Basic ), or simple coverage ( Traditional ).
Biologics:
Biologics is a class of drug used to treat diseases that are caused by or result from abnormal cell growth. Biologics can be either living organisms or non-living substances such as proteins, hormones, and enzymes. The most commonly used biologic for leg ulcer treatment is sirolimus (Rapidin) which works by decreasing the production of prostaglandins in the body.
Application Insights:
The hospital application segment dominated the global leg ulcers treatment market in 2017 owing to factors such as availability of advanced healthcare facilities and skilled staff, high prevalence of chronic diseases, and rising number of surgeries. According to WHO, in 2016, around 1.3 billion people had some form of chronic disease worldwide which accounted for about 30% of the population. Moreover, an estimated 9 million people died due to these diseases that year which amounted to about 3% mortality rate globally. These statistics indicate a significant unmet clinical need with respect to leg ulcers treatment across the globe where resources are scarce and there is a growing demand for cost-effective solutions that provide better outcomes at lower costs.
The clinic application segment is expected witness lucrative growth over the forecast period owing to increasing awareness among patients regarding early diagnosis.
Regional Analysis:
Europe dominated the global leg ulcers treatment market in 2017. The presence of well-developed healthcare infrastructure, high awareness levels coupled with rising patient disposable income are some of the factors responsible for its large share. In addition, reimbursement policies in this region are more favorable towards advanced products and treatments which is further fueling their adoption. For instance, in May 2018 France legalized reimbursement for all patients regardless of whether they had incurred the expense or not (unlike other countries where a portion is reimbursed).
Asia Pacific is expected to witness lucrative growth over the forecast period owing to increasing government initiatives & programs along with growing medical tourism industry supported by low cost treatment options offered by various countries such as India & China & Australia etc.
Growth Factors:
- Increasing incidence of leg ulcers
- Rising awareness about leg ulcers and their treatment options
- Growing demand for minimally invasive procedures for treating leg ulcers
- Technological advancements in the field of leg ulcer treatment
- increasing healthcare expenditure
Scope Of The Report
Report Attributes
Report Details
Report Title
Leg Ulcers Treatment Market Research Report
By Type
Wound Care Dressings, Biologics, Therapy Devices, Others
By Application
Hospital, Clinic
By Companies
3M, Smith & Nephew, Molnlycke Health Care, ConvaTec, Coloplast, Integra LifeSciences, Essity (BSN Medical), Medline, B. Braun, Organogenesis
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
238
Number of Tables & Figures
167
Customization Available
Yes, the report can be customized as per your need.
Global Leg Ulcers Treatment Market Report Segments:
The global Leg Ulcers Treatment market is segmented on the basis of:
Types
Wound Care Dressings, Biologics, Therapy Devices, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- 3M
- Smith & Nephew
- Molnlycke Health Care
- ConvaTec
- Coloplast
- Integra LifeSciences
- Essity (BSN Medical)
- Medline
- B. Braun
- Organogenesis
Highlights of The Leg Ulcers Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Wound Care Dressings
- Biologics
- Therapy Devices
- Others
- By Application:
- Hospital
- Clinic
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Leg Ulcers Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
There is no one-size-fits-all answer to this question, as the best treatment for leg ulcers will vary depending on the individual's specific symptoms and medical history. However, some common treatments for leg ulcers include:nnu2013 Oral antibiotics: This is typically the first line of treatment for most leg ulcers. Antibiotics help to fight off infection and can help improve healing time.nu2013 Hydrocortisone cream or ointment: This medication can help reduce inflammation and pain associated with leg ulcers. It may also be helpful in speeding up healing time.nu2013 Surgery: If oral antibiotics are not effective or if a patient does not respond well to them, surgery may be necessary to remove the lesion or repair damage done by it.
Some of the major players in the leg ulcers treatment market are 3M, Smith & Nephew, Molnlycke Health Care, ConvaTec, Coloplast, Integra LifeSciences, Essity (BSN Medical), Medline, B. Braun, Organogenesis.
The leg ulcers treatment market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Leg Ulcers Treatment Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Leg Ulcers Treatment Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Leg Ulcers Treatment Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Leg Ulcers Treatment Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Leg Ulcers Treatment Market Size & Forecast, 2018-2028
4.5.1 Leg Ulcers Treatment Market Size and Y-o-Y Growth
4.5.2 Leg Ulcers Treatment Market Absolute $ Opportunity
Chapter 5 Global Leg Ulcers Treatment Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Leg Ulcers Treatment Market Size Forecast by Type
5.2.1 Wound Care Dressings
5.2.2 Biologics
5.2.3 Therapy Devices
5.2.4 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Leg Ulcers Treatment Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Leg Ulcers Treatment Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinic
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Leg Ulcers Treatment Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Leg Ulcers Treatment Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Leg Ulcers Treatment Analysis and Forecast
9.1 Introduction
9.2 North America Leg Ulcers Treatment Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Leg Ulcers Treatment Market Size Forecast by Type
9.6.1 Wound Care Dressings
9.6.2 Biologics
9.6.3 Therapy Devices
9.6.4 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Leg Ulcers Treatment Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinic
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Leg Ulcers Treatment Analysis and Forecast
10.1 Introduction
10.2 Europe Leg Ulcers Treatment Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Leg Ulcers Treatment Market Size Forecast by Type
10.6.1 Wound Care Dressings
10.6.2 Biologics
10.6.3 Therapy Devices
10.6.4 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Leg Ulcers Treatment Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinic
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Leg Ulcers Treatment Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Leg Ulcers Treatment Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Leg Ulcers Treatment Market Size Forecast by Type
11.6.1 Wound Care Dressings
11.6.2 Biologics
11.6.3 Therapy Devices
11.6.4 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Leg Ulcers Treatment Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinic
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Leg Ulcers Treatment Analysis and Forecast
12.1 Introduction
12.2 Latin America Leg Ulcers Treatment Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Leg Ulcers Treatment Market Size Forecast by Type
12.6.1 Wound Care Dressings
12.6.2 Biologics
12.6.3 Therapy Devices
12.6.4 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Leg Ulcers Treatment Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinic
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Leg Ulcers Treatment Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Leg Ulcers Treatment Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Leg Ulcers Treatment Market Size Forecast by Type
13.6.1 Wound Care Dressings
13.6.2 Biologics
13.6.3 Therapy Devices
13.6.4 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Leg Ulcers Treatment Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinic
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Leg Ulcers Treatment Market: Competitive Dashboard
14.2 Global Leg Ulcers Treatment Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 3M
14.3.2 Smith & Nephew
14.3.3 Molnlycke Health Care
14.3.4 ConvaTec
14.3.5 Coloplast
14.3.6 Integra LifeSciences
14.3.7 Essity (BSN Medical)
14.3.8 Medline
14.3.9 B. Braun
14.3.10 Organogenesis
